C92.0 - Acute myeloblastic leukemia
- Applicable to Acute myeloblastic leukemia
- The 2025 edition of ICD10-CM C92.0 became effective on October 1, 2024.
- This is the American ICD10-CM version of C92.0 - other international versions of ICD10 C92.0 may differ.
- C92.0 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- C92.0 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- C92.0 - Acute myeloblastic leukemia
- C92.0 - Acute myeloblastic leukemia
- C92.00 - Acute myeloblastic leukemia, not having achieved remission
- C92.01 - Acute myeloblastic leukemia, in remission
- C92.02 - Acute myeloblastic leukemia, in relapse
Inclusion Term
- Acute myeloblastic leukemia, minimal differentiation
- Acute myeloblastic leukemia (with maturation)
- Acute myeloblastic leukemia 1/ETO
- Acute myeloblastic leukemia M0
- Acute myeloblastic leukemia M1
- Acute myeloblastic leukemia M2
- Acute myeloblastic leukemia with t(8;21)
- Acute myeloblastic leukemia (without a FAB classification) NOS
- Refractory anemia with excess blasts in transformation [RAEB T]
Type 1 Excludes
- acute exacerbation of chronic myeloid leukemia (C92.10)
- refractory anemia with excess of blasts not in transformation (D46.2-)
The following codes above C92.0 contain annotation back-references that may be applicable to C92.0:
Chapter: C00-D49 Neoplasms
Section: C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue
Category: C92 Myeloid leukemia
Non-Billable/Non-Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com